Tamara D Rozental 1 2, Kempland C Walley 1, Serkalem Demissie 3, Signe Caksa 4, Adriana Martinez-Betancourt 4, Amber M Parker 1, Joy N Tsai 4 5, Elaine W Yu 4 5, Mary L Bouxsein 1 2 4 J Bone Miner Res. 2018 […]
Daysi Duarte Sosa 1, Erik Fink Eriksen 2 Calcif Tissue Int. 2017 Jul;101(1):34-42. doi: 10.1007/s00223-017-0256-5. Epub 2017 Feb 28. PMID: 28246929 DOI: 10.1007/s00223-017-0256-5 The aim of the study
Xavier Nogués 1, Daniel Prieto-Alhambra 2, Roberto Güerri-Fernández 1, Natalia Garcia-Giralt 3, Jaime Rodriguez-Morera 1, Lourdes Cos 1, Leonardo Mellibovsky 1, Adolfo Díez Pérez 4 Bone. 2017 Oct;103:64-69. doi: 10.1016/j.bone.2017.06.018. Epub 2017 Jun 24. PMID: 28655603 DOI: 10.1016/j.bone.2017.06.018 Background: Some
F Malgo 1, N A T Hamdy 1, S E Papapoulos 1, N M Appelman-Dijkstra 2 Osteoporos Int. 2017 Aug;28(8):2433-2437. doi: 10.1007/s00198-017-4054-8. Epub 2017 May 2. PMID: 28466137 PMCID: PMC5524858 DOI: 10.1007/s00198-017-4054-8 We
R Rudäng 1, M Zoulakis 1, D Sundh 1, H Brisby 2, A Diez-Perez 3, L Johansson 1, D Mellström 1, A Darelid 1, M Lorentzon 4 Osteoporos Int. 2016 Apr;27(4):1585-1592. doi: 10.1007/s00198-015-3419-0. Epub 2015 Dec 2. PMID: 26630975 PMCID: PMC4791463 DOI: 10.1007/s00198-015-3419-0
Daysi Duarte Sosa 1, Erik Fink Eriksen 1 Acta Orthop. 2016 Dec;87(6):626-631. doi: 10.1080/17453674.2016.1198883. Epub 2016 Jun 20. PMID: 27321443 PMCID: PMC5119447 DOI: 10.1080/17453674.2016.1198883 Background and purpose – Bone
Frank Malgo 1, Neveen A T Hamdy, Socrates E Papapoulos, Natasha M Appelman-Dijkstra J Clin Endocrinol Metab. 2015 May;100(5):2039-45. doi: 10.1210/jc.2014-4346. Epub 2015 Mar 13. PMID: 25768670 DOI: 10.1210/jc.2014-4346
M Schoeb 1, F Malgo 1, J J M Peeters 1, E M Winter 1, S E Papapoulos 1, N M Appelman-Dijkstra 2 Osteoporos Int. 2020 Sep;31(9):1683-1690. doi: 10.1007/s00198-020-05375-3. Epub 2020 Apr 8. PMID: 32270252
I K Blom-Høgestøl 1, T Mala 2, J A Kristinsson 2, C Brunborg 3, H L Gulseth 4, E F Eriksen 5 Bone. 2020 Jan;130:115069. doi: 10.1016/j.bone.2019.115069. Epub 2019 Oct 5. PMID: 31593823 DOI: 10.1016/j.bone.2019.115069 Background:
E Lerma-Chippirraz 1 2, Marta Pineda-Moncusí 3, A González-Mena 1, Jade Soldado-Folgado 1 2, H Knobel 1, M Trenchs-Rodríguez 2, A Díez-Pérez 1 2, Todd T Brown 4, N García-Giralt 3, R Güerri-Fernández 1 2 J Antimicrob Chemother. 2019 May 1;74(5):1381-1388. doi: 10.1093/jac/dkz014. PMID: 30768163 PMCID: PMC7967828
Indication For Use and Safety Information
The OsteoProbe is indicated for use as a measurement tool to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. The device is not intended to diagnose or treat any clinical condition.
Like with any percutaneous procedure, there is a small risk of infection. The sale, distribution, and use of the OsteoProbe are restricted to prescription use. Federal law (United States of America) restricts this device to use by, or on the order of, a physician.
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy